Interní Med. 2005; 7(7): 342-345

CURRENT TREATMENT OF VIRAL HEPATITIS

doc. MUDr. Petr Husa CSc
Klinika infekčních chorob, FN Brno

Viral hepatitis still represents a serious health problem above all in the developing countries. The treatment of acute viral hepatitis is only symptomatic. For the treatment of chronic hepatitis B four have been licensed in the Czech Republic - pegylated interferon alpha-2a, standard interferon alpha, lamivudine and adefovir dipivoxil. Treatment with pegylated interferon alpha and ribavirin is now the standard of chronic hepatitis C therapy worldwide.

Keywords: Key words: viral hepatitis, pegylated interferon alpha, standard interferon alpha, lamivudine, adefovir dipivoxil, ribavirin.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Husa P. CURRENT TREATMENT OF VIRAL HEPATITIS. Interní Med. 2005;7(7):342-345.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Conjeevaram HS, Lok ASF. Management of chronic hepatitis B. J Hepatol 2003; 38 (Suppl. 1): S90-S103. Go to original source... Go to PubMed...
    2. Galský J, Husa P, Kümpel P, Němeček V, Plíšek S, Šperl J, Urbánek P, Volfová M (abecedně). Diagnostika a léčba chronické virové hepatitidy C (HCV). Doporučený postup České hepatologické společnosti a Společnosti infekčního lékařství z roku 2002. Klin mikrobiol inf lék 2003; 9: 54-56.
    3. Husa P, Husová L. Chronické virové hepatitidy v ordinaci praktického lékaře. Spolupráce praktika a hepatologa. 1. vyd. Praha: Triton 2002; 28s.
    4. Husa P, Husová L. Hepatitida C. Diagnostické možnosti praktického lékaře z pohledu infektologa. Practicus 2004; 3: 258-260.
    5. Husa P, Husová L. Virové hepatitidy. 1. vyd. Praha: Galén 2005, 247 s.
    6. Husa P, Plíšek S, Šperl J, Urbánek P (koordinátoři), Galský J, Hůlek P, Kümpel P, Němeček V, Volfová M (abecedně). Diagnostika a léčba chronické virové hepatitidy B. Doporučený postup České hepatologické společnosti a Společnosti infekčního lékařství - aktualizace červen 2005. Dostupné na http://www.ceska-hepatologie.cz.
    7. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-1745. Go to original source... Go to PubMed...
    8. Lok ASF, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000 - Summary of a workshop. Gastroenterology 2000; 120: 1828-1853. Go to original source... Go to PubMed...
    9. Lok ASF, McMahon BJ: Chronic hepatitis B: update of recommendations. AASLD Practice Guideline. Hepatology 2004; 39: 857-861. Go to original source... Go to PubMed...
    10. Němeček V. Sérologický přehled ČR v roce 2001 - virová hepatitida A, B, C. Zprávy CEM 2003; 12: 55-61.
    11. Strader DFB, Wright T, Thomas DL, Seeff L. Diagnosis, management, and treatment of hepatitis C. AASLD Practice Guideline. Hepatology 2004; 39: 1147-1171. Go to original source... Go to PubMed...
    12. The EASL Jury. EASL International Consensus Conference on Hepatitis B, 13-14 September, 2002, Geneva, Switzerland. Consensus Statement (Long version). J Hepatol 2003; 39 (Suppl.1): S3-S25. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.